BioSpace News Archive

Business

Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, announced its financial results for the second quarter ended June 30, 2021, and recent business highlights.

August 10, 2021
·
8 min read
Business

Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update

Foghorn Therapeutics Inc. today provided a corporate update in conjunction with the Company’s From 10-Q filing for the quarter ended June 30, 2021.

August 10, 2021
·
6 min read
Business

Aldevron’s Collaboration with Ginkgo Bioworks Yields Manufacturing Breakthrough for Vaccinia Capping Enzyme Used for Manufacturing of mRNA Vaccines

Aldevron and Ginkgo Bioworks , Inc. (“Ginkgo”) today announced a manufacturing breakthrough driven by their strategic partnership.

August 10, 2021
·
9 min read
Biotech Bay

Second Genome Presents Preclinical Data Demonstrating the Effects of Microbial-Derived Metabolites in Autism Spectrum Disorder

Second Genome presented data from the largest analysis of microbiome function in Autism Spectrum Disorder (ASD)

August 10, 2021
·
4 min read
Genetown

Gemini Therapeutics to Participate in the H.C. Wainwright Ophthalmology Conference

Gemini Therapeutics, Inc. today announced that Jason Meyeburg, Chief Executive Officer of Gemini Therapeutics, is scheduled to participate virtually in the H.C. Wainwright Ophthalmology Conference on Tuesday, August 17 at 9:00 AM ET.

August 10, 2021
·
1 min read
SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations

CoronaVac® generates good immune memory after second dose. Third dose of vaccine significantly increased neutralizing antibody levels in adults and elderly population.

August 10, 2021
·
7 min read
Business

Novanta Announces Financial Results for the Second Quarter 2021

Novanta Inc. today reported financial results for the second quarter 2021.

August 10, 2021
·
29 min read
Business

Abeona Therapeutics Appoints Edward Carr as Chief Financial Officer

Abeona Therapeutics Inc. today announced the appointment of Edward Carr as Chief Financial Officer and Principal Financial Officer, effective immediately.

August 10, 2021
·
3 min read
Business

Verrica Pharmaceuticals Reports Second Quarter 2021 Financial Results

Verrica Pharmaceuticals Inc. today announced financial results for the second quarter ended June 30, 2021.

August 10, 2021
·
12 min read
Business

Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical TrialOn track to initiate Phase 2 trial in the first quarter of 2022

Kaleido Biosciences, Inc. today announced a strategic collaboration with the COPD Foundation to study KB109 in patients with chronic obstructive pulmonary disease (COPD).

August 10, 2021
·
7 min read